HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics

Not Applicable

Completed

• Conditions: Alcohol or Other Drugs Use

• Registration Number: NCT02294318
• Lead Sponsor: Research Foundation for Mental Hygiene, Inc.

Brief Summary

This pilot study goal is to compare two different treatments to help HIV positive patients reduce their concurrent drinking and non-injection drug use.

Detailed Description

The goal of this study is to compare the effects of brief motivational interviewing with participation in HealthCall to brief motivational interviewing alone on non-injection drug and alcohol use. HealthCall involves 2-3 minutes of daily smartphone use to track drug use, drinking behaviors and other aspects of health, followed by personalized feedback in a graph after 30 and 60 days of using the smartphone.

Study Timeline

• Study First Submitted: 2014-11-17
• Study First Submitted QC: 2014-11-17
• Study First Posted: 2014-11-19
• Study Start: 2015-06
• Primary Completion: 2016-01
• Study Completion: 2016-03
• Results First Submitted: 2018-04-10
• Results First Submitted QC: 2019-02-22
• Results First Posted: 2019-06-03
• Status Verified: 2021-08
• Last Update Submitted: 2021-08-15
• Last Update Posted: 2021-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

Age 18 and older; 2. During the prior 30 days, > 4 days of non-injection of cocaine, methamphetamine or heroin, one of which is identified by the patient as his/her primary drug During prior 30 days, > 1 day of binge drinking (>4 drinks on one occasion); Completion of medically supervised detoxification if such detoxification is required; HIV Positive ; Able to give informed consent

Exclusion Criteria

Patient is currently psychotic, suicidal, or homicidal. Patient has injected any drug in the last 6 months Patient has definite plans to leave the greater New York metropolitan area within the study period.

Patient has gross cognitive/psychomotor impairment as evidenced on the Halstead-Reitan Trails (A+B) Patient does not speak English or Spanish Patient has a hearing and/or vision impairment that precludes smartphone use.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean Number of Days Used Primary Drug (NumDU)	60 days	This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Dollar Amount Spent Per Day on Primary Drug (QuantU)	60 days	This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Number of Drinking Days (NumDD)	60 days	This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).
Mean Number of Drinks Per Day (QuantDD)	60 days	This outcome was derived from a Timeline Follow Back (TLFB) completed at the end of the intervention (day 60).

Trial Locations

Locations (1)

The New York State Psychiatric Institute; 🇺🇸 New York, New York, United States